Disruption of ubiquitin-mediated processes in diseases of the brain and bone

Biochemical Society Transactions

Volumn 36, Issue 3, 2008, Pages 469-471

  Layfield, Robert ^a   Searle, Mark S ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Neurodegenerative disorder; p62; Paget's disease of bone (PDB); Sequestosome 1 (SQSTM1); Ubiquitin; Ubiquitin associated domain (UBA domain)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEIN P62; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UBIQUITIN;

ALZHEIMER DISEASE; CELL FUNCTION; CONFERENCE PAPER; ENZYME MECHANISM; GENE DISRUPTION; GENE MUTATION; HUMAN; MOLECULAR DYNAMICS; OSTEOCLAST; PAGET BONE DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BONE DISEASES; BRAIN DISEASES; HUMANS; MUTATION; NEURODEGENERATIVE DISEASES; UBIQUITIN;

EID: 45249097838     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360469     Document Type: Conference Paper

References (28)

1. Mori, H., Kondo, J. and Ihara, Y. (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644
2. Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., Landon, M. and Mayer, R.J. (1998) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J. Pathol. 155, 9-15
3. Zatloukal, K., French, S.W., Stumptner, C., Strnad, P., Harada, M., Toivola, D.M., Cadrin, M. and Omary, M.B. (2007) From Mallory to Mallory-Denk bodies: what, how and why? Exp. Cell Res. 313, 2033-2049
4. Layfield, R., Lowe, J. and Bedford, L. (2005) The ubiquitin-proteasome system and neurodegenerative disorders. Essays Biochem. 41, 157-171
5. Pickart, C.M. and Fushman, D. (2004) Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 8, 610-616
6. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K. and Ihara, Y. (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10, 1151-1160
7. Cripps, D., Thomas, S.N., Jeng, Y., Yang, F., Davies, P. and Yang, A.J. (2006) Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J. Biol. Chem. 281, 10825-10838
8. Hardy, J., Cai, H., Cookson, M.R., Gwinn-Hardy, K. and Singleton, A. (2006) Genetics of Parkinson's disease and parkinsonism. Ann. Neurol. 60, 389-398
9. Bence, N.F., Sampat, R.M. and Kopito, R.R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555
10. Vernace, V.A., Schmidt-Glenewinkel, T. and Figueiredo-Pereira, M.E. (2007) Aging and regulated protein degradation: who has the UPPer hand? Aging Cell 6, 599-606
11. Lam, Y.A., Pickart, C.M., Alban, A., Landon, M., Jamieson, C., Ramage, R., Mayer, R.J. and Layfield, R. (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 97, 9902-9906
12. Hurley, J.H., Lee, S. and Prag, G. (2006) Ubiquitin-binding domains. Biochem. J. 399, 361-372
13. Kuusisto, E., Kauppinen, T. and Alafuzoff, I. (2007) Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol. Appl. Neurobiol. 34, 169-180
14. Seibenhener, M.L., Geetha, T. and Wooten, M.W. (2007) Sequestosome 1/P62: more than just a scaffold. FEBS Lett. 581, 175-179
15. Pankiv, S., Clausen, T.H., Lamark, T., Brech, A., Bruun, J.A., Outzen, H., Øvervatn, A., Bjørkøoy, G. and Johansen, T. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol. Chem. 282, 24131-24145
16. Seibenhener, M.L., Babu, J.R., Geetha, T., Wong, H.C., Krishna, N.R. and Wooten, M.W. (2004) Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol. 24, 8055-8068
17. Tan, J.M., Wong, E.S., Kirkpatrick, D.S., Pletnikova, O., Ko, H.S., Tay, S.P., Ho, M.W., Troncoso, J., Gygi, S.P., Lee, M.K. et al. (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet. 17, 431-439
18. Layfield, R. (2007) The molecular pathogenesis of Paget disease of bone. Expert Rev. Mol. Med. 9, 1-13
19. Laurin, N., Brown, J.P., Morissette, J. and Raymond, V. (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70, 1582-1588
20. Hocking, L.J., Lucas, G.J.A., Daroszewska, A., Mangion, J., Olavesen, M., Nicholson, G.C., Ward, L., Bennett, S.T., Wuyts, W., Van Hul, W. and Ralston, S.H. (2002) Domain specific mutations in Sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum. Mol. Genet. 11, 2735-2739
21. Cavey, J.R., Ralston, S.H., Hocking, L.J., Sheppard, P.W., Ciani, B., Searle, M.S. and Layfield, R. (2005) Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J. Bone Miner. Res. 20, 619-624
22. Cavey, J.R., Ralston, S.H., Sheppard, P.W., Ciani, B., Gallagher, T.R., Long, J.E., Searle, M.S. and Layfield, R. (2006) Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone. Calcif. Tissue Int. 78, 271-277
23. Layfield, R. and Shaw, B. (2007) Ubiquitin-mediated signalling and Paget's disease of bone. BMC Biochem. 8 (Suppl. 1), S5
24. Wooten, M.W., Geetha, T., Seibenhener, M.L., Babu, J.R., Diaz-Meco, M.T. and Moscat, J. (2005) The p62 scaffold regulates nerve growth factor-induced NF-κB activation by influencing TRAF6 polyubiquitination. J. Biol. Chem. 280, 35625-35629
25. Martin, P., Diaz-Meco, M.T. and Moscat, J. (2006) The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation. EMBO J. 25, 3524-3533
26. Ciani, B., Layfield, R., Cavey, J.R., Sheppard, P.W. and Searle, M.S. (2003) Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. J. Biol. Chem. 278, 37409-37412
27. Long, J., Gallagher, T.R., Cavey, J.R., Sheppard, P.W., Ralston, S.H., Layfield, R. and Searle, M.S. (2008) Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. J. Biol. Chem. 283, 5427-5440
28. 63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J. Biol. Chem. 279, 7055-7063